References
- CorriePGCytotoxic chemotherapy: clinical aspectsMedicine20083612428
- EgyüdLGSzent-GyörgyiACancerostatic action of methylglyoxalScience196816011405647441
- AppleMAGreenbergDMArrest of cancer in mice by therapy with normal metabolites. II. Indefinite survirors among mice treated with mixtures of 2-oxopropanal (NSC-79019) and 2,3-dihydroxypropanal (NSC67934)Cancer Chemother Rep19685276876965743708
- ConroyPJCarcinostatic activity of methylglyoxal and related substances in tumour-bearing miceCiba Found Symp197867271300159813
- ElvinPSlaterTFAnti-tumour activity of novel adducts of ascorbic acid with aldehydesEur J Cancer Clin Oncol1981177597657199470
- RayMRaySMethylglyoxal: from a putative intermediate of glucose breakdown to its role in understanding that excessive ATP formation in cells may lead to malignancyCurr Sci199875103113
- BiswasSRayMMisraSDuttaDPRaySSelective inhibition of mitochondrial respiration and glycolysis in human leukaemic leukocytes by methylglyoxalBiochem J19973233433489163322
- HalderJRayMRaySInhibition of glycolysis and mitochondrial respiration of Ehrlich ascites carcinoma cells by methylglyoxalInt J Cancer1993544434498509219
- GhoshMTalukdarDGhoshSBhattacharyyaNRayMRaySIn vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Augmentation of the curative effect of methylglyoxal on cancer-bearing mice by ascorbic acid and creatineToxicol Appl Pharmacol2006212455816112157
- BhattacharyyaNPalAPatraSHaldarAKRoySRayMActivation of macrophages and lymphocytes by methylglyoxal against tumor cells in the hostInt Immunopharmacol200881503151218617020
- PalABhattacharyaIBhattacharyaKMandalCRayMMethylglyoxal induced activation of murine peritoneal macrophages and surface markers of T lymphocytes in sarcoma-180 bearing mice: involvement of MAP kinase, NF-kappa beta signal transduction pathwayMol Immunol2009462039204419375802
- TalukdarDRaySDasSJainAKKulkarniARayMTreatment of a number of cancer patients suffering from different types of malignancies by methylglyoxal-based formulation: a promising resultCancer Ther20064B205222
- TalukdarDRaySRayMDasSA brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patientsDrug Metabol Drug Interact20082317521018533369
- InoueYKimuraAMethylglyoxal and regulation of its metabolism in microorganismsAdv Microb Physiol1995371772278540421
- RackerEThe mechanism of action of glyoxalaseJ Biol Chem195119068569614841219
- SuriSSFenniriHSinghBNanotechnology-based drug delivery systemsJ Occup Med Toxicol200721618053152
- ChenSCWuYCMiFLLinYHYuLCSungHWA novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug deliveryJ Control Release20049628530015081219
- DevABinulalNSAnithaAPreparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applicationsCarbohydr Polym2010803833838
- KumarMNMuzzarelliRAMuzzarelliCSashiwaHDombAJChitosan chemistry and pharmaceutical perspectivesChem Rev20041046017608415584695
- QiLFXuZRLiYJiangXHanXYIn vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cellsWorld J Gastroenterol200511335136514116127742
- ChakrabartiATalukdarDPalARayMImmunomodulation of macrophages by methylglyoxal conjugated with chitosan nanoparticles against Sarcoma-180 tumor in miceCell Immunol2014287273524368179
- FonsecaCSimõesSGasparRPaclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release200283227328612363453
- YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release200068341943110974396
- BhadraDBhadraSJainSJainNKA PEGylated dendritic nanoparticulate carrier of fluorouracilInt J Pharm20032571–211112412711167
- PanyamJLabhasetwarVSustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticlesMol Pharm200411778415832503
- BishtSMaitraADextran-doxorubicin/chitosan nanoparticles for solid tumor therapyWiley Interdiscip Rev Nanomed Nanobiotechnol2009141542520049807
- TricklerWJNagvekarAADashAKA novel nanoparticle formulation for sustained paclitaxel deliveryAAPS Pharm Sci Tech200892486493
- SinhaRKimGJNieSShinDMNanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug deliveryMol Cancer Ther200651909191716928810
- PatraSGhoshARoySSA short review on creatine-creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapyAmino Acids2012422319233021769499
- CooperRAMethylglyoxal synthaseMethods Enzymol197541502508236480
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods19836555636606682
- RayMHalderJDuttaSKRaySInhibition of respiration of tumor cells by methylglyoxal and protection of inhibition by lactaldehydeInt J Cancer1991476036091995489
- BekesiJGMolnarZWinzlerRJInhibitory effect of d-glucosamine and other sugar analogs on the viability and transplantability of ascites tumor cellsCancer Res1969293533595765417
- RayMBasuNRaySInactivation of glyceraldehyde-3-phosphate dehydrogenase of human malignant cells by methylglyoxalMol Cell Biochem199717721269450641
- RaySBiswasSRayMSimilar nature of inhibition of mitochondrial respiration of heart tissue and malignant cells by methylglyoxal. A vital clue to understand the biochemical basis of malignancyMol Cell Biochem1997171951039201701
- RaySDuttaSHalderJRayMInhibition of electron flow through complex I of the mitochondrial respiratory chain of Ehrlich ascites carcinoma cells by methylglyoxalBiochem J199430369727945267
- MillerEEEvansAECohnMInhibition of rate of tumor growth by creatine and cyclocreatineProc Natl Acad Sci U S A199390330433088475072
- KristensenCAAskenasyNJainRKKoretskyAPCreatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studiesBr J Cancer19997922782859888469